» Articles » PMID: 2164529

Incidence of Antibodies Blocking Thyrotropin Effect in Vitro in Patients with Euthyroid or Hypothyroid Autoimmune Thyroiditis

Overview
Specialty Endocrinology
Date 1990 Jul 1
PMID 2164529
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Autoantibodies blocking the TSH-dependent production of cAMP in thyroid cells (TSH-BAb) have been described in atrophic thyroiditis (AT; idiopathic myxedema) and in neonates with transient hypothyroidism, but their incidence in autoimmune thyroiditis in relation to thyroid status remains to be completely established. To this purpose TSH-BAb were evaluated in a group of 140 consecutive patients with autoimmune thyroiditis, which included 26 cases of AT and 114 subjects with goitrous Hashimoto's thyroiditis (HT); among the goitrous group 27 were euthyroid (HT-E), 32 had subclinical hypothyroidism (HT-SH), and 55 had clinical hypothyroidism (HT-H). TSH-BAb were measured in immunoglobulin G prepared by DEAE-Sephadex A-50 by determining their ability to inhibit TSH-dependent cAMP production in a differentiated strain of cultured rat thyroid cells (FRTL-5). Using this sensitive and reproducible method, TSH-BAb were detected in 12 of 26 (46%) patients with AT, in 1 of 27 (3.7%) subjects with HT-E, in 3 of 32 (9.4%) with HT-SH, and in 20 of 55 (36%) with HT-H. The prevalence of TSH-BAb was higher in AT vs. HT-H (P less than 0.001), HT-SH (P less than 0.001), or HT-E (P less than 0.001), and in HT-H vs. HT-SH (P less than 0.001) or HT-E (P less than 0.001). Mean TSH-BAb levels in AT were higher than those in HT-H (P less than 0.005) and HT-SH (P less than 0.025); the difference was not significant between HT-H and HT-SH. An inverse correlation was found between TSH-BAb levels and estimated goiter weight (P less than 0.005). The results of the present study indicate that 1) in autoimmune thyroiditis TSH-BAb are detectable almost exclusively in hypothyroid patients, their prevalence being higher in overt hypothyroidism than in subclinical thyroid failure; 2) the prevalence of TSH-BAb and their mean levels are higher in hypothyroid patients with AT than in those with HT; and 3) therefore, the presence of circulating TSH-BAb appears to be related to the development of hypothyroidism and thyroid atrophy.

Citing Articles

Non-Conventional Clinical Uses of TSH Receptor Antibodies: The Case of Chronic Autoimmune Thyroiditis.

Napolitano G, Bucci I, Di Dalmazi G, Giuliani C Front Endocrinol (Lausanne). 2021; 12:769084.

PMID: 34803929 PMC: 8602826. DOI: 10.3389/fendo.2021.769084.


Investigation of TSH receptor blocking antibodies in childhood-onset atrophic autoimmune thyroiditis.

Nagasaki K, Nakamura A, Yamauchi T, Kamasaki H, Hara Y, Kanno J Clin Pediatr Endocrinol. 2021; 30(2):79-84.

PMID: 33867667 PMC: 8022035. DOI: 10.1297/cpe.30.79.


Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves' Orbitopathy.

George A, Diana T, Langericht J, Kahaly G Front Endocrinol (Lausanne). 2021; 11:629925.

PMID: 33603715 PMC: 7885640. DOI: 10.3389/fendo.2020.629925.


Thyrotropin Receptor Blocking Antibodies.

Diana T, Olivo P, Kahaly G Horm Metab Res. 2018; 50(12):853-862.

PMID: 30286485 PMC: 6290727. DOI: 10.1055/a-0723-9023.


Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review.

Seo S, Sanchez Robledo M J Endocrinol Invest. 2018; 41(12):1457-1468.

PMID: 30194634 DOI: 10.1007/s40618-018-0945-6.